Skip to main content
. 2021 May 14;57(4):326–341. doi: 10.1007/s10593-021-02912-8

Figure 2.

Figure 2.

Nucleoside analogs with a modified heterocyclic fragment (Het = uracil-1-yl, 5-fluorouracil-1-yl, 5-bromouracil-1-yl, 5-iodouracil-1-yl, thymin-1-yl, cytisin-1-yl, adenin-9-yl, 2,4-dioxo- 3,4-dihydroquinazolin-1(2H)-yl, n = 1, 3, 4).